<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our data suggest that ex vivo bone marrow purging using monoclonal antibodies (MoAbs) and sheep-anti-mouse immunobeads (<z:chebi fb="75" ids="15414">SAM</z:chebi> beads) prior to autologous bone marrow transplantation (ABMT) allows satisfactory <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell reduction without critical stem cell losses </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless, there is only a reduction but no elimination of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>The consequences will have to be clinically discussed </plain></SENT>
</text></document>